Znaczenie rokownicze kontroli glikemii w ostrych zespołach wieńcowych u chorych na cukrzycę.
Piśmiennictwo
1. Norhammar A,
Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., Malmberg K. Glucose metabolism
in patients with acute myocardial infarction and no previous diagnosis of
diabetes mellitus:A prospective study. Lancet. 2002;359:2140‑2144
2. Capes S.E., Hunt
D., Malmberg K., Gerstein H. Stress hyperglycaemia and increased risk of death
after myocardial infarction in patients with and without diabetes:a systematic
overview. Lancet. 2000;355:773‑778
3. Wahab N.N.,
Cowden E.A., Pearce N.J., Gardner M.J., Merry H., Cox J.L. Is blood glucose and
independent predictor of mortality in acute myocardial infarction in the
thrombolytic era? Journ. Am. Coll. Cardiol. 2002;40:1748‑1754
4. Sala J., Masia
R., Gonzalez de Molina F.J., Fernandez-Real J.M., Gil M., Bosch D., Ricart W.,
Senti M., Marrugat J. REGICOR Investigators. Short-term mortality of myocardial
infarction patients with diabetes or hyperglycaemia during admission. J.
Epidemiol. Community Health. 2002;56:707‑712
5. Iwakura K, Ito
H., Ikushima M., Kawano S., Okamura A., Asano K. K, Kuroda T, Tanaka K,
Masuyama T, Hori M, Fujii K. Association between hyperglycemia and the
no-reflow phenomenon in patients with acute myocardial infarction. A. Am. Coll.
Cardiol. 2003;41:1‑7
6. Malmberg K.,
Norhammar A., Wedel H., Ryden L. Glycometabolic state at admission:important
risk marker of mortality in conventionally treated patients with diabetes
mellitus and acute myocardial infarction:long-term results from the Diabetes
and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study.
Circulation 1999;99:2626‑2632
7. Malmberg K.,
Ryden L., Wedel H., Birkeland K., Bootsma A, Dickstein K., Efendic S., Fisher
M., Hamsten A., Herlitz J., Hildebrandt P., MacLeod K., Laakso M.,
Torp-Pedersen C., Waldenstrom A. for the DIGAMI 2 Investigators. Intense
metabolic control by means of insulin in patients with diabetes mellitus and
acute on mortality and morbidity. Eur Heart J, 2005, 26, 650‑661
8. Metha S.R., Ysuf
S., Diaz R., Zhu J., Pais P., Xavier D., Paolasso E., Ahmed R., Xie C., Kazmi
K., Tai J., Orlandini A., Pogue J., Liu L. CREATE-ECLA Trial Group
Investigators. Effect of glucose-insulin-potassium infusion on mortality in
patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA
randomized controlled trial. JAMA. 2005;293:437‑446
9. American Diabetes
Association. Clinical Practice Recommendations 2007. Standards of Medical Care
in Diabetes. Diabetes Care. 2007;30 Suppl.
1:S4‑S41
10. Polskie Towarzystwo Diabetologiczne. Zalecenia
kliniczne dotyczące postępowania u chorych na cukrzycę 2007. Diabetologia
Praktyczna. 2007;8, supl. A
11. The Task Force
on Diabetes and Cardiovascular Diseases of the European Society of Cardiology
(ESC) and of the European Association for the Study of Diabetes (EASD).
Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive
summary. European Heart Journal. 2007;28:88‑136
